1.gif (1892 bytes)

Editorial

Indian Pediatrics 2003; 40:701-703 

Political Will and the Promotion of Breastfeeding

 

Pediatricians want to improve child health and survival. Poverty, pathogens and ignorance are their enemies but commercial capital and marketing manipulation are also powerful adversaries. For over a century, motivated by high profits, the manufacturers of artificial infant feeding products have promoted their products through a series of overt and subtle strategies. The global value of baby food sales is now over US$16,453 million (78,978 crore rupees)(1). The resulting loss of confidence in breastfeeding has had devastating results. Health services worldwide, including in rich countries, are overloaded with preventable morbidity, and the poor endure many unnecessary infant deaths(2).

Breastfeeding research (to which Indian scientists have made an impressive contribu-tion), using more rigorous study designs, continues to reveal powerful evidence of the value of breastfeeding and breastmilk(3-5).

There is a dose-related response to different feeding patterns. Exclusive breastfeeding for the first six months significantly reduces morbidity and mortality(6). This practice, followed by continued breastfeeding, together with nutrient-dense complementary feeding, into the second year and beyond, is the cornerstone of WHO/UNICEF’s Global Strategy for Infant and Young Child Feeding(7). Almost all mothers can achieve this if given skilled practical, emotional and social support, feasible even in poor slum communities in India(5). The realisation that hypertension(8), obesity(9) and diabetes(10) are influenced by infant feeding patterns has restimulated interest in industrialised societies, as does the evidence of the health benefits for women. For example, each year of breastfeeding independently reduces the risk of breast cancer by 4.3%(11). Women in Europe and North America, aware of the benefits to their children and themselves, are finding ways to breastfeed for longer.

The International Code of Marketing of Breastmilk Substitutes (the Code) was adopted by the World Health Assembly (WHA) in 1981 to stop the damage to breastfeeding through promotion of the substitute products. Apathy on the part of governments, lack of breastfeeding knowledge in the medical establishment and the guile of the companies contributed to inertia in implementation of the Code(12) However, thanks to the persistence of individuals and organisations, often linked with the International Baby Food Action Network (IBFAN), and the intrinsic ethical and moral content of the Code, its aims are gaining ground. The biennial WHA Resolutions have clarified ambiguities and addressed new health and development issues. The Code is designed to protect the breastfeeding mother from misinformation and undermining practices, and the infant who must be artificially fed, through impartial feeding decisions untainted by commercial influences. It also shields health professionals who individually may find it difficult to withstand the blandishments of the companies.

Research has shown that the companies will flout the Code where they can, but will curb their excesses when governments act(13). To date 25 countries have enacted the full Code as law(14). India achieved this in 1992 through the Infant Milk Substitute Act (IMS). Moreover, India included tools for implementation through the wise step of utilising the expertise of citizens’ organisations, particularly the Association of Consumer Action on Safety and Health (ACASH) and the Breastfeeding Promotion Network of India (BPNI). Prosecutions, or the threat of legal action, have made companies back off and eschew practices which are rampant in other countries. Nestle were forced to change misleading labels, and Johnson and Johnson were stopped from pushing feeding bottles. But loopholes in the law allowed continuing exploitation.

Perhaps the most successful promotional strategies of the companies is their financial sponsorship and gift inducements for the medical profession, both through professional bodies and to individuals. For this reason the WHA adopted Resolution WHA 49(14) in 1996. Concern was expressed that "health institutions and ministries may be subject to subtle pressure to accept, inappropriately, financial and other support for professional training in infant and child health"; Member States were urged "to ensure that the financial support for professionals working in infant and young child health does not create conflict of interest, especially with regard to the WHO/UNICEF Baby Friendly Hospital Initiative."

The Lok Sabha and the Rajya Sabha have approved the Infant Milk Substitutes, Feeding Bottles, and Infant Foods Regulation of Pro-duction, Supply and Distribution Amendment Bill 2003 (IMSAB) which has closed the loopholes in the IMS Act of 1992. This is exactly the aim of the global consensus of the WHA Resolutions. The WHO/UNICEF Global Strategy for Infant Feeding emphasises rapid implementation of the Code and all subsequent resolutions. India is at the helm of this flagship of infant and young child health protection.

The IMSAB comprehensively bans all forms of promotion of infant feeding products, including offering any kind of benefits to any person. Funding of seminars, meetings, research or any sponsorship is prohibited. The beauty of this legislation is that it lifts the individual’s ethical responsibility into a communal one and lightens the burden. Many readers of this journal may have been recipients of gifts and sponsorship from these manufacturers. This entrenched practice was established way back in the 1920s in the United Kingdom and North America. No one need wallow in guilt and everyone may rejoice in a move towards ethical practice knowing the law is on their side.

In the USA, a recent analysis of the nature and effect of sponsorship on doctors showed that 61% of physicians believe that promotions do not influence their own practice but only 16% believed this about other physicians. Small gifts have as potent effect as large. "The sheer ubiquity of trinkets.......is evidence of effectiveness; why else would profit -minded companies continue to provide them? Thus policies against gifts should not be limited to large gifts." All gifts subliminally influence, thus undermining the quality of clinical decision-making. The authors argue cogently how unconscious and unintentional is the recipient’s bias towards the gift-giver and state that a policy of prohibition is the only answer(15). India has done just that.

This Indian law will support the excellence in practice for which every paediatrician strives and they have a key role in its implementation. Monitoring is crucial and notification must be swift to help compliance become established. Many doctors may need to update themselves in breastfeeding management skills and pre-service curricula reform must gather momentum. Fortunately, materials are at hand available for national and local use (Breastfeeding counselling: A training course. WHO/UNICEF publication).

The implementation of this law gives all paediatricians the chance to invest in the true wealth of India, the health and wellbeing of her children. India, through democracy and the skill of dedicated citizens, has had the political will to bring the Code and subsequent WHA Resolutions into effect. The health and development of Indian children is being taken seriously.

Gabrielle Palmer,
Research Fellow,
Nutrition Unit,
London School of Hygiene and
Tropical Medicine, U.K.
E-mail: [email protected]

Anthony Costello,
Professor of International Child Health,
International Perinatal Care Unit,
Institute of Child Health,
University College, London, U.K.
E-mail: [email protected]

 

 References


1. Euromonitor International. The world market for baby food, 2001

2. WHO collaborative Study Team on the Role of Breastfeeding on the prevention of infant mortality. Effect of breastfeeding on infant anf childhood mortality due to infectious diseases in less developed countries: A pooled analysis. Lancet, 2000, 355: 451 455.

3. Sachdev HPS, Krishna J, Puri RK, Satya-narayana L, Kumar S. Water supplementation in exclusively breastfed infants during summer in the tropics. Lancet 1991; 337(8747): 929-933.

4. Narayanan I., Prakash K., Murthy N. S., Gujral V. V. Randomised controlled trial of effect of raw and holder pasteurised human milk and of formula supplements on incidence of neonatal infection. Lancet 1984; ii: 1111-1113.

5. Bhandari N, Bahl R, Mazumdar S, Martines J, Black RE, Bhan MK. Effect of community-based promotion of exclusive breastfeeding on diarrhoeal illness and growth: a cluster randomised controlled trial. Lancet 2003; 361: 1418-1423.

6. Arifeen S, Black RE, Antelman G, Baqui A, Caulfield L, Becker S. Exclusive breastfeeding reduces acute respiratory infection and diarrhea deaths among infants in Dhaka slums. Pediatrics 2001; 108(4): 1-8.

7. WHO, Global Strategy for Infant and Young Child Feeding, web document, 2003. http://who.int/child.adplescent-health

8. Roberts SB. Prevention of hypertension in adulthood by breastfeeding? Commentary. Lancet 2001; 357: 406-407.

9. Von Kries R, Koletzo B, Saurerwals T, von Mutis E, Barnet D, Grunert V. Breastfeeding and obesity: cross sectional study. British Medical Journal 1999; 319: 147-150.

10. Working group on Cow’s Milk Protein and Diabetes mellitus (American Academy of Pediatrics). Infant Feeding practices and their possible realtionship to the etiology of Diabetes mellitus. Pediatrics 1994; 94: 752-754.

11. Collaborative Group on Hormonal Factors in Breast Cancer. Breast cancer and breastfeeding. Collaborative reanalysis of individual data from 47 epidemiological studies in 30 countries. Lancet 2002; 360: 187-195.

12. Palmer, Gabrielle. The Politics of Breastfeeding. Pandora Press, London, 1993.

13. Costello A, Sachdev HPS. Protecting breast-feeding from breastmilk substitutes. British Medical Journal 1998; 316: 1103-1104.

14. UNICEF. National implementation of the International Code of Marketing of Breastmilk Substitutes, Nutrition Section, New York, January 2003.

15. Dana J and Loewenstein G. A social science perspective on gifts to physicians from industry. JAMA 2003; 290: 252-255.

 

Home

Past Issue

About IP

About IAP

Feedback

Links

 Author Info.

  Subscription